Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-028993
Filing Date
2024-06-18
Accepted
2024-06-18 21:45:33
Documents
1
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718761526.html 4  
1 FORM 4 wk-form4_1718761526.xml 4 3358
  Complete submission text file 0001628280-24-028993.txt   4804
Mailing Address 307 WESTLAKE AVE. NORTH, STE 300 SEATTLE WA 98109
Business Address
Azelby Robert (Reporting) CIK: 0001656998 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39071 | Film No.: 241053900

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Issuer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)